Finally, we investigated the rescue of these observed phenotypes with a small molecule activator of TRPML1, previously shown to rescue the phenotype associated with mutations in FIG4 [46], allowing us to propose a potential therapeutic target common to more than one subtype of CMT. Here, FIG4 is linked to Charcot-Marie-Tooth disease.